Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Ondansetron (2mg) + Ranitidine (25mg)
Therapeutic Category
Gastroenterology, Antacid
Dosage Form
Injection
Packaging Type
Combi Pack
Packaging
2*2
Price
₹19/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Ranilair O Injection is a combination formulation of Ondansetron, an antiemetic, and Ranitidine, an H2-receptor antagonist, designed to provide effective relief for nausea, vomiting, and gastric acid-related issues. Ondansetron works by blocking the action of serotonin, which is responsible for triggering nausea and vomiting, particularly after surgery or chemotherapy. Ranitidine helps in reducing the production of stomach acid, preventing conditions like acid reflux and ulcers. This combination is particularly useful for patients undergoing medical treatments such as chemotherapy, radiation, or post-operative recovery, where nausea and acid-related discomfort are common.
The synergy of Ondansetron and Ranitidine in Ranilair O Injection helps in controlling both nausea and gastric acid secretion, promoting patient comfort during critical recovery phases.
Possible side effects include headache, dizziness, constipation, diarrhea, abdominal pain, or fatigue.
Indicated for the prevention of nausea and vomiting associated with chemotherapy, radiation therapy, and post-operative recovery, as well as for managing conditions related to excess stomach acid.
Consult a doctor before use, especially if you have liver problems, are pregnant, or breastfeeding.
Store at room temperature, away from direct sunlight and moisture. Protect from freezing. Keep out of reach of children.
Composition : Granisetron (1mg) Injection
Composition : Ondansetron (2mg)
Composition : Tigecycline (50mg) Injection
Composition : Teicoplanin (400mg) Injection
Composition : Teicoplanin (200mg) Injection
Composition : Polymyxin B (500000IU) Injection
Composition : Piperacillin (4000mg) + Tazobactum (500mg)
Composition : Piperacillin (2000mg) + Tazobactum (250mg)
Composition : Piperacillin (1000mg) + Tazobactum (125mg)
Composition : Meropenem (1000mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination injection has strong demand in the hospital care, gastroenterology, emergency care, and post-operative care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable anti-emetic and gastric care portfolios.
Medical distributors and agencies can benefit from consistent demand for nausea, vomiting, and gastric acidity management in hospital settings under medical supervision. Ondansetron 2mg is a 5-HT3 receptor antagonist used to control nausea and vomiting Ranitidine 25mg is an H2 receptor antagonist that reduces gastric acid secretion Commonly used for post-operative nausea and vomiting, gastritis-related vomiting, acidity with nausea, and hospital-based supportive care Helps provide dual action: anti-emetic effect + gastric acid suppression Widely used in hospitals, emergency units, and surgical wards Prescribed by physicians, surgeons, and critical care specialists This strengthens a comprehensive hospital injectable and gastro care portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Ondansetron + Ranitidine Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong hospital demand, surgical usage, emergency care orders, reliable supply chain support, and attractive margins in the injectable gastro segment.
Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality product ranges, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.